What Happens in Vegas: PEP to PrEP Opportunities
| Status: | Recruiting |
|---|---|
| Conditions: | HIV / AIDS, HIV / AIDS, HIV / AIDS |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/15/2018 |
| Start Date: | September 1, 2018 |
| End Date: | August 31, 2019 |
| Contact: | John (Rob) Phoenix, MSN, APRN |
| Email: | jphoenixaprn@gmail.com |
| Phone: | 702-979-1111 |
What Happens in Vegas: Identifying Opportunities to Expand an HIV Prevention Network to Improve PEP and PrEP Delivery
Observational study looking at barriers to care for individuals seeking care, Post Exposure
Prophylaxis (PEP) after an actual or perceived exposure to HIV. Following PEP treatment
subjects will be asked about there intent to transition to Pre-Exposure Prophylaxis (PrEP)
and surveyed about barriers to care or perceptions of care
Prophylaxis (PEP) after an actual or perceived exposure to HIV. Following PEP treatment
subjects will be asked about there intent to transition to Pre-Exposure Prophylaxis (PrEP)
and surveyed about barriers to care or perceptions of care
The primary objective of this study is to assess the rate of engagement in a PEP to PrEP HIV
provider network for those patients presenting following a non-occupational HIV exposure.
The development of a referral network and intensive clinical follow up of PEP patients will
result in more patients appropriately initiating PEP, being referred to appropriate follow
up, and post exposure transition and maintaining on PrEP (if indicated) at completion of the
PEP medications.
provider network for those patients presenting following a non-occupational HIV exposure.
The development of a referral network and intensive clinical follow up of PEP patients will
result in more patients appropriately initiating PEP, being referred to appropriate follow
up, and post exposure transition and maintaining on PrEP (if indicated) at completion of the
PEP medications.
Inclusion Criteria:
- Actual or perceived non-occupational exposure to HIV, by self report, within 72 hours
of enrollment and referred for care
- able and willing to provide informed consent
- available for 12 months of post expoure follow-up Southern Nevada Ryan White defined
service area
Exclusion Criteria:
- HIV+ at time of screeing via 4th genderation (Antibody/Antigen) testing
- Current PEP and/or PrEP product condrainidications as listed in the medication product
insert.
We found this trial at
1
site
Las Vegas, Nevada 89104
Principal Investigator: John Phoenix, APRN
Phone: 702-979-1111
Click here to add this to my saved trials
